Background
Methods
Study design, area and population
Sampling
Serology
Statistical analysis
Results
The sociodemographic and clinical data of the participants
Variables | CCTH n = 217 (55.1%) | CCMH n = 28 (7.1%) | SMH n = 149 (37.8%) | Total N (%) |
---|---|---|---|---|
Age (years) | ||||
≤ 19 | 6 (2.8) | 1 (3.6) | 5 (3.4) | 12 (3.1) |
20–29 | 21 (9.7) | 8 (28.6) | 15 (10.1) | 44 (11.2) |
30–39 | 61 (28.1) | 6 (21.4) | 51 (34.2) | 118 (30.0) |
40–49 | 76 (35.0) | 8 (28.6) | 41 (27.5) | 125 (31.7) |
50–59 | 42 (19.4) | 4 (14.3) | 25 (16.8) | 71 (18.0) |
≥ 60 | 11 (5.1) | 1 (3.6) | 12 (8.1) | 24 (6.1) |
Median (IQR) | 42 (34.5–49) | 36 (26.7–543) | 41 (35–49.5) | 41 (34–49) |
Gender | ||||
Male | 49 (22.6) | 4 (14.3) | 43 (28.9) | 96 (24.4) |
Female | 168 (77.4) | 24 (85.7) | 106 (71.1) | 298 (75.6) |
Educational status | ||||
None | 46 (21.2) | 5 (17.9) | 26 (17.4) | 77 (19.5) |
Basic | 136 (62.7) | 17 (60.7) | 104 (69.8) | 257 (65.2) |
Secondary | 23 (10.6) | 6 (21.4) | 13 (8.7) | 42 (10.7) |
Tertiary | 12 (5.5) | 0 (0.0) | 6 (4.0) | 18 (5.6) |
Employment | ||||
Unemployed | 35 (16.1) | 5 (17.9) | 23 (15.4) | 63 (16.0) |
informal | 163 (75.1) | 22 (78.6) | 115 (77.2) | 300 (76.1) |
formal | 19 (8.8) | 1 (3.6) | 11 (7.4) | 31 (7.9) |
Marital status | ||||
Single | 36 (16.6) | 6 (21.4) | 21 (14.1) | 63 (16.0) |
Married/Cohabiting | 121 (55.8) | 19 (67.9) | 78 (52.4) | 218 (55.3) |
Widow/widower | 32 (14.8) | 1 (3.6) | 20 (13.4) | 53 (13.5) |
Divorced | 28 (12.9) | 2 (7.1) | 30 (20.1) | 60 (15.2) |
Residence | ||||
Rural | 147 (67.7) | 19 (67.9) | 100 (67.1) | 266 (67.5) |
Urban | 70 (32.3) | 9 (32.1) | 49 (32.9) | 128 (32.5) |
Variables | CCTH n = 217 (55.1%) | CCMH n = 28 (7.1%) | SMH n = 149 (37.8%) | Total N (%) |
---|---|---|---|---|
HIV patients | ||||
Newly confirmed cases | 29 (13.4) | 7 (25.0) | 11 (7.4) | 47 (11.9) |
Old cases | 188 (86.6) | 21 (75.0) | 138 (92.6) | 347 (88.1) |
WHO clinical stage | ||||
Stage 1 | 137 (63.1) | 20((71.4) | 114 (76.5) | 271 (68.8) |
Stage 2 | 52 (24.0) | 4 (14.3) | 22 (14.8) | 78 (19.8) |
Stage 3 | 21 (9.7) | 1 (3.6) | 7 (4.7) | 29 (7.4) |
Stage 4 | 7 (3.2) | 3 (10.7) | 6 (4.0) | 16 (4.1) |
HBV/HCV status before testing | ||||
HBV known | 19 [4*] (21.1) | 0 (0) | 12(P = 1; 8.3) | 31 (7.9) |
HBV unknown | 198 (91.2) | 28 (100) | 137 (91.9) | 363 (92.1) |
HCV unknown | 217 (100) | 28 (100) | 149 (100) | 394 (100) |
HBV and HCV seroprevalence among the participants
Variables | N (%) | Seroprevalence of HBV coinfection (%) | P value | Seroprevalence of HCV coinfection (%) |
---|---|---|---|---|
Age (years) | ||||
≤ 19 | 12 (3.1) | 0 (0.0) | 0.464 | 0 (0.0) |
20–29 | 44 (11.2) | 1 (2.3) | 0 (0.0) | |
30–39 | 118 (30.0) | 11 (9.3) | 1 (0.9) | |
40–49 | 125 (31.7) | 8 (6.4) | 1 (0.8) | |
50–59 | 71 (18.0) | 3 (4.2) | 0 (0.0) | |
≥ 60 | 24 (6.1) | 1((4.2) | 0 (0.0) | |
Gender | ||||
Male | 96 (24.4) | 5 (5.2) | 0.809 | 0 (0.0) |
Female | 298 (75.6) | 19 (6.4) | 2 (0.7) | |
Educational status | ||||
None | 77 (19.5) | 5 (6.5) | 0.903 | 1 (1.3) |
Basic | 257 (65.2) | 17 (6.6) | 0 (0.0) | |
Secondary | 42 (10.7) | 2 (4.8) | 1 (2.4) | |
Tertiary | 18 (5.6) | 0 (0.0) | 0 (0.0) | |
Employment | ||||
Unemployed | 63 (16.0) | 3 (4.7) | 0.188 | 1 (1.6) |
Informal | 300 (76.1) | 20 (6.7) | 1 (0.3) | |
Formal | 31 (7.9) | 1 (3.2) | 0 (0.0) | |
Marital status | ||||
Single | 63 (16.0) | 2 (3.2) | 0.240 | 0 (0.0) |
Married/Cohabiting | 218 (55.3) | 16 (7.3) | 2 (0.9) | |
Widow/widower | 53 (13.5) | 1 (1.9) | 0 (0.0) | |
Divorced | 60 (15.2) | 5 (8.3) | 0 (0.0) | |
Residence | ||||
Rural | 266 (67.5) | 17 (6.4) | 1.000 | 2 (0.8) |
Urban | 128 (32.5) | 7 (5.5) | 0 (0.0) | |
HIV patients | ||||
Newly confirmed cases | 47 (11.9) | 1 (2.1) | 0.376 | 0 (0.0) |
Old cases | 347 (88.1) | 23 (6.6) | 2 (0.6) | |
WHO clinical stage | ||||
Stage 1 | 271 (68.8) | 10 (3.7) |
0.004
| 0 (0.0) |
Stage 2 | 78 (19.8) | 12 (15.4) | 1 (1.3) | |
Stage 3 | 29 (7.4) | 2 (6.9) | 0 (0.0) | |
Stage 4 | 16 (4.1) | 0 (0.0) | 1 (6.3) | |
HBV/HCV status after testing in this study | ||||
HBV | 394 | 19/394 (5. 3)a; 5/394 (1.27)b | ||
HCV | 394 (100) | 2 (0.5) | ||
Total hepatitis seroprevalence | 26 (6.6) | 24 (6.1) | 2 (0.5) |